NATALIE DUNCAN: Open Payments
NPI 1265293153 · RIVERSIDE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 48 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,057 · 2025 $1,011
Food & beverage: $912Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $147 |
| Janssen Biotech, Inc. | 3 | $141 |
| Almirall LLC | 6 | $128 |
| Incyte Corporation | 4 | $105 |
| UCB, Inc. | 3 | $62 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $57 |
| Amgen Inc. | 3 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| LEO Pharma Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $40 |
Products named: TREMFYA, OPZELURA, Seysara, RINVOQ, Bimzelx, SKYRIZI, Otezla, COSENTYX.
Industry payments across MO — which companies pay providers there.
